1. Why is erectile dysfunction (impotence) sometimes a side effect of surgery (whether robotic or open procedure) for prostate cancer?

A: The nerves that control erectile function are in close proximity to the prostate. These nerves can be damaged with surgery. Robotic surgery enables the surgeon to visualize the nerves and carefully dissect them away so that they are not damaged during surgery. Learn More>> Robotic surgery for prostate cancer

2. Why is erectile dysfunction (impotence) sometimes a side effect of radiation therapy for prostate cancer?

A: Radiation and X-Rays can sometimes damage the nerves that surround the prostate which are responsible for erectile function. Learn More>> Radiation therapy options for prostate cancer

3. What are my options for treatment of erectile dysfunction after prostate cancer surgery?

A: Treatment options include oral medications such as Viagra (Sildenafil), Levitra (Vardenafil), or Cialis (Tadalafil) as well as more aggressive forms of therapy like Muse (Alprostadil) which is a small pellet that is placed into the opening at the tip of the penis, or injectable medications. A vacuum erection device if also recommended to help with return of erections. Learn More>> Impotence after prostate cancer surgery

4. When should I start treatment for erectile dysfunction after surgery for prostate cancer?

A: In general, the earlier one starts treatment the better. Following any treatment for prostate cancer, it is important to keep blood flow to the penis. Whether or not sexual relations are resumed, erectile rehabilitation should begin. Generally, once urinary control has returned is a good time to start erectile rehabilitation.

We encourage you to contact our Patient Navigator at (678) 843-5665 or renee.sevy@emoryhealthcare.org with any questions you have regarding erectile dysfunction.

Information on this page is provided collaboratively by the team at the Prostate Cancer Center at Saint Joseph's and has been medically reviewed by Rajesh G. Laungani, MD, 2010. The PCC follows American Urological Association and  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for the treatment of prostate cancer.

Last Updated: October 14, 2010 (RSH